Brooks, D A <br/><br/>
Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models.  [electronic resource] 

 -  Biochimica et biophysica acta  Aug 1997 
 - 203-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-3002 
<br/><br/><label>Standard No.: </label>10.1016/s0925-4439(97)00036-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies--blood<br/>Antibody Formation<br/>Anxiety--etiology<br/>Cats<br/>Cyanosis--etiology<br/>Dose-Response Relationship, Drug<br/>Fever--etiology<br/>Humans<br/>Mucopolysaccharidosis VI--drug therapy<br/>N-Acetylgalactosamine-4-Sulfatase<br/>Rats<br/>Recombinant Proteins--adverse effects<br/>Respiration--drug effects<br/>Sulfatases--adverse effects<br/>Tissue Distribution<br/>Vomiting--etiology